{"id":"NCT01635881","sponsor":"Boston Scientific Corporation","briefTitle":"Evaluation of Coronary Luminal Diameter Enlargement With Emerge™ 1.20 mm PTCA Dilatation Catheter","officialTitle":"EMERGE: Evaluation of Coronary Luminal Diameter Enlargement With Emerge™ 1.20 mm Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilatation Catheter","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-07","primaryCompletion":"2012-12","completion":"2012-12","firstPosted":"2012-07-10","resultsPosted":"2013-11-06","lastUpdate":"2013-11-06"},"enrollment":60,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Coronary Artery Disease"],"interventions":[{"type":"DEVICE","name":"Emerge™ 1.20 mm PTCA Dilatation Catheter","otherNames":[]}],"arms":[{"label":"Emerge","type":"EXPERIMENTAL"}],"summary":"To evaluate the acute safety and device procedural success of the Emerge 1.20 mm PTCA dilatation catheter when used as a pre-dilatation device in the stenotic portion of coronary arteries or bypass grafts.","primaryOutcome":{"measure":"Device Procedural Success","timeFrame":"Peri-procedural","effectByArm":[{"arm":"Emerge","deltaMin":98.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":60},"commonTop":["Myocardial infarction","Blood creatinine abnormal","Cardiac enzymes increased","Urine analysis abnormal","Colon cancer"]}}